Myriad Genetics, Inc.

Q2 2024 13F Holders

Symbol
MYGN
CUSIP
62855J104
Type
Equity
Class
COM
Num filings
231
Total reported value, excl. options
$2.30 B
Manager Report Date Value ($000) Shares Option Type